DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
DeGagne - 2 VCs - 2 Sari Kaganoff - 2 it's - 2 Ro - 2 Kaganoff - 2 Aaron DeGagne - 2 Alyson Watson - 1
Top related locs:
Ozempic GLP
Top related orgs:
Health - 2 Business - 2 Rock Health - 2 Getty - 2 PitchBook - 2 Modern Health - 1 Lennox - 1 BI - 1

Search resuls for: "DeGagne"


3 mentions found


☆ These are the 13 mental health startups that could IPO, make acquisitions, or get bought this year, according to analysts
  + stars: | 2024-05-15 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +3 min
Modern HealthModern Health provides personalized mental health treatment to employers, including coaching and therapy. Lennox-Miller said it's unlikely Modern Health could snag the same valuation from its last fundraise in a deal today. DeGagne said employer-focused mental health startups such as Modern Health have the potential for more profitable growth with "stickier" recurring revenue models. He said pharmacy giants Walgreens or CVS Health might seek to pick up a mental health asset like Modern Health. In a statement provided by Modern Health, Forrester senior analyst Jonathan Roberts said, "Modern Health is certainly a partner with its finger on the pulse.
Persons: Alyson Watson, Alexander Lennox, Miller, fundraise, DeGagne, Forrester, Jonathan Roberts Organizations: Modern Health, Health, Lennox, BI, Modern, Walgreens, CVS Health, CVS
☆ 3 titans will fight to dominate the market for Wegovy in 2024
  + stars: | 2023-12-27 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +5 min
Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity. The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year. But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December. WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch. Ro launched its own program prescribing weight-loss drugs in January.
Persons: VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne Organizations: Business, Rock Health, Web, Getty, PitchBook Locations: Ozempic
☆ VCs are getting pickier about their weight-loss bets as startups rush to prescribe Ozempic
  + stars: | 2023-12-11 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +8 min
Read previewWith the Ozempic craze in full swing, investors are getting picky about the weight-loss startups they want to back. Kaganoff predicted that in the new year some startups prescribing GLP-1s would invest more money in studies using real-world evidence to show their programs work. And despite the Ozempic frenzy, weight-loss startups captured a tiny fraction of the money invested this year. Investors had put about $211 million toward weight-loss startups through mid-November, representing about 3% of digital-health funding over that period, according to PitchBook. Alfie HealthSome unlikely sectors of the healthcare industry stand to benefit from the growth of the weight-loss market.
Persons: —, Sari Kaganoff, Crystal Cox, Kaganoff, Ro, VCs, Michael Greeley, Alyssa Jaffee, 7wireVentures, she's, she'd, Mounjaro, Mercer, Michael Siluk, PitchBook, Alfie Health, it's, Alfie's cofounders, Aaron DeGagne, Jordan, he'd, DeGagne, There's Organizations: Service, Business, Rock Health, Flare Capital Partners, Getty, Employers, Health, Investors, Phenomix Sciences, Mayo Clinic, PitchBook, Tusk Venture Partners, Sword Health Locations: GLP
0 next >>
Total: 3